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ABSTRACT: Perinatal nutrition programs physiologic and metabolic functions, with consequences on the suscepti-
bility to developmetabolic diseases in adulthood. Themicrobiota represents a key factor of suchprogramming.We
investigated whether perinatal prebiotic [short-chain fructooligosaccharides (scFOS)] supplementation improved
adult metabolic health in association with microbiota changes in pigs used as human model. Sows were supple-
mented with scFOS or not during the end of gestation and the entire lactation, and offspring received scFOS
accordingly during 1 mo after weaning. Pigs were then fed a standard diet for 5 mo, followed by a high-fat diet for
3mo once adults. Perinatal scFOS supplementation induced a persistentmodulation of the composition of the fecal
microbiota in adulthood, notably by increasing the Prevotella genus. Meanwhile, scFOS animals displayed im-
proved capacity to secrete glucagon-like peptide-1 and improved pancreas sensitivity to glucose without any
changes in peripheral insulin sensitivity. Perinatal scFOS supplementation also increased ileal secretory IgA se-
cretionandalkalinephosphataseactivityanddecreasedTNF-a expression inadipose tissue. Inconclusion,perinatal
scFOS supplementation induced long-lastingmodulation of intestinalmicrobiota andhadbeneficial consequences
on thehost physiology in adulthood.Our resultshighlight thekey role of perinatal nutritionon latermicrobiota and
hostmetabolic adaptation to anunbalanced diet.—LeBourgot, C., Ferret-Bernard, S.,Apper, E., Taminiau, B., Cahu,
A., Le Normand, L., Respondek, F., Le Hue¨rou-Luron, I., Blat, S. Perinatal short-chain fructooligosaccharides pro-
gram intestinal microbiota and improve enteroinsular axis function and inflammatory status in high-fat diet-fed
adult pigs. FASEB J. 33, 000–000 (2019). www.fasebj.org
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The developmental origins of health and disease concept,
based on substantial epidemiologic evidences and exper-
imental data (1, 2), stipulates that adult metabolic health
may be programmed by environmental factors, including
nutrition, during perinatal life. The early stages of life,
from the fetal life to the end of early childhood in humans
(2 yr old), are a critical window of sensitivity to such
programming.
The role of the microbiota in programming physiology
and metabolism has recently emerged. Exposure to anti-
biotics in infancy, for example, has long-lasting conse-
quences on the intestinalmicrobiota composition (3, 4) and
on overweight andmetabolic status (5–7). The underlying
mechanisms are not fully understood butmay involve the
known crosstalk between the microbiota and host physi-
ology. For instance, bacterial metabolites, such as short-
chain fatty acids (SCFAs), namely acetate and propionate,
enhance the release of glucagon-like peptide-1 (GLP-1) by
L-cells of the distal small intestine and proximal colon
through the activation of the G-protein-coupled free fatty
acid receptor 2 (8). GLP-1, also termed incretin, is an in-
testinal hormoneknown topotentiate theglucose-induced
insulin secretion, and interestingly, it also stimulatesb-cell
neogenesis and proliferation and inhibits their apoptosis,
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thereby increasing b-cell mass and insulin-secretion ca-
pacity (9). This specific communication between the gut
and thepancreas,which ismandatory tomaintain glucose
homeostasis, has been integrated under the concept of the
enteroinsular axis. Intestinal microbiota, influencing this
enteroinsular communication, can therefore modulate
host glucose homeostasis.
The infant microbiota is shaped by early environment
as delivery mode and maternal dietary habits in humans
and animalmodels (10–12). In fact, it is very influenced by
the microbiota of its mother, from passage through the
placenta and fromthebirth canal tobreastfeedingand skin
contact (13). The favoringof the colonizationof a beneficial
microbiota in infancy, generating, for instance, beneficial
metabolites for the host, could be a good way to promote
health later in life.
Prebiotic fibers are good candidates to modulate
microbiota positively. They are selectively fermented in-
gredients that allow specific changes of the intestinal
microbiota, both in composition and metabolism, confer-
ring benefits on the host well-being and health (14). The
impact of the consumption of a diet supplemented with
prebiotics during pregnancy and lactation on offspring
health has not been studied extensively but deserves
attention as a result of the influence of prebiotics on
microbiota composition and activity. Short-chain fruc-
tooligosaccharides (scFOS) are highly interesting prebiotic
fibers, obtained from sucrose and consisting of 2–4 fruc-
tose units linked to 1 glucose molecule, which are selec-
tively fermented by thegutmicrobiota, promoting growth
of Lactobacillus, Bifidobacterium, Akkermensia, and Blautia
coccoidesmainly, as well as SCFA production (15–18). The
high degree of similarity between the gut microbiota of
mothers supplemented with scFOS and that of their off-
spring in mice, 2 wk after birth (19), suggests that im-
provement of the profile of maternal gut microbiota does
enhance early colonization of the offspring gut through
bacterial transfer in utero, at birth, andduring suckling.We
previously demonstrated in pigs that maternal scFOS
supplementation induced an increased fermentative ac-
tivity of the offspring microbiota during lactation with a
higher butyrate production after weaning (20), com-
pared with offspring of nonsupplemented sows. We
also observed a long-lasting effect of the perinatal scFOS
supplementation on microbiota metabolite production,
.2 mo after the end of supplementation (21), suggesting
a persistent effect of early scFOS supplementation on
microbiota composition. Consequently, it seems possible
tomodulate the early colonizationof thegutmicrobiota by
a maternal prebiotic supply with a persistent effect on the
microbiota composition and SCFA distal gut content.
However, to our knowledge, the consequences of such a
microbiotamodulationon thephysiologyandmetabolism
of the host have not been investigated. Our hypothesis is
that the establishment of a favorable microbiota in neo-
nates by perinatal consumption of prebiotics could have a
positive impact on the developmental trajectory of the
intestine and pancreas, enabling individuals to cope met-
abolically better with an unbalanced diet as adults.
Therefore, we investigated whether perinatal scFOS sup-
plementation could impact thegutmicrobiota and thehost
physiology, enteroinsular axis, andglucosehomeostasis in
adult offspring.
For such purpose, we supplemented sows with scFOS
during the last third of gestation and the entire lactation
and went on the supplementation of their offspring for 1
mo afterweaning. Given evidence that the developmental
programming effects of early nutrition can be latent, adult
pigs received anunbalanceddiet during 3mo to reveal the
potential effects of early scFOS supplementation on pro-
grammingof their enteroinsular axis andmetabolichealth.
MATERIALS AND METHODS
Animals, diets, and experimental design
The experimental protocol was designed in compliance with
legislations of the European Union (directive 86/609/EEC)
and France (decree 2001-464 29/05/01) for the care and use of
laboratory animals (agreement for animal housing number
C-35-275-32). The regional Ethics Committee in Animal
Experiments approved the procedure described herein
(2016020217308570). Twenty-nine sows (large white 3 land-
race) and their piglets [(large white 3 landrace) 3 Pietrain]
from the INRA (Saint-Gilles, France) experimental herd were
used in 2 replicates [n = 17 in the first replicate (R1) and n = 12
in the second replicate (R2)]. From 28 d before the presumed
day of farrowing, sows were fed a standard diet (Cooperl,
Lamballe, France), supplemented with either scFOS (95% of
scFOS with molecular chain length between 3 and 5 mono-
meric units; Profeed P95; Beghin-Meiji, Marckolsheim,
France; scFOS group; n = 14) or maltodextrin as a control
[Maldex; Tereos Starch & Sweeteners Europe, Marckolsheim,
France; control (CTRL) group; n = 15; Fig. 1]. Sowswere given
3 kg d21 feed during gestation and were fed ad libitum during
lactation, resulting in an approximate daily intake of 10 g
scFOS over the experimental gestation and lactation periods,
as detailed previously (21). Before weaning, sow-reared pig-
lets had no access to creep feed. At weaning [postnatal day
(PND) 28], piglets were fed ad libitum a commercial starter
diet, supplementedwith 0.15% scFOS (n = 37) ormaltodextrin
(CTRL; n = 42), according to thematernal diet, during 4–7 wk.
This early postweaning period corresponds to the onset of
food diversification in humans; this is why we decided to
cover this periodwith scFOS supplementation too, in addition
to maternal supplementation. Then, pigs were randomly se-
lected to be used further in the experiment [n = 17 CTRL (10
from R1 and 7 from R2) and n = 18 scFOS (11 from R1 and 7
fromR2)] and reared on a commercial growing diet until 6 mo
of age, followed by a high-fat (HF), high-energetic diet, for-
mulated at INRA to provide 22.6% of energy from lipids, until
9 mo of age (PND 274; Fig. 1). Offspring body weight was
measured weekly until weaning and then every 2 wk during
the supplementation period. From PND 155 (5 wk before the
introduction of the HF diet), pigs were weighed weekly until
the end of the experiment. Pigs were monitored daily for food
intake, as well as for fever or diarrhea. No medication or an-
tibiotic treatment was administered throughout the experi-
mental protocol. Composition of sow diets and pig diets is
provided in Supplemental Table 1.
Fecal and blood sample collection
Fecal and blood samples were collected at different stages of
development during the experiment. Fecal samples were
collected from a subset of piglets at PND 21, 50, 190, 211, and
253 to analyze microbiota composition (PND 21, n = 6 per
group; PND 190, n = 6 per group; PND 253, n = 6 per group)
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and to determine the evolution of SCFAproduction (n = 7 per
group and per age; Fig. 1). For microbiota analysis, sub-
samples of feces were stored immediately at 280°C after
collection without any treatment, whereas for SCFA analy-
sis, 1 ml 0.5% ortho-phosphoric acid solution per gram of
feces was added, and samples were centrifuged at 1700 g for
15 min at 4°C. Supernatants were then stored at 220°C for
later analysis. Blood was collected in a subset of piglets at
PND 21 (n = 91 CTRL and n = 79 scFOS) and after weaning at
PND 77 (n = 42 CTRL and n = 37 scFOS), PND 190 (n = 17
CTRL and n = 18 scFOS), and PND 253 (n = 17 CTRL and n =
18 scFOS) in tubes containing EDTA. After centrifugation at
2500 g for 10 min at 4°C, plasma samples were stored at
220°C for further analysis of glucose, insulin, and inflam-
matory marker concentrations.
16S rRNA high-throughput sequencing of
fecal microbiota
Genomic DNAwas extracted from feces using a QIAamp DNA
Stool Mini Kit (Qiagen, Hilden, Germany), according to the
manufacturer’s instructions, including a bead-beating step. PCR
amplification of the V1–V3 region of the 16S rDNA and library
preparationwas performed as previously described (22). In brief,
PCR amplification of the V1–V3 region of the 16S rDNA and
library preparation was performed with the following primers
(with Illumina overhand adapters): forward (59-GAGAGTTT-
GATYMTGGCTCAG-39) and reverse (59-ACCGCGGCTGCT-
GGCAC-39). Each PCRproductwas purifiedwith theAgencourt
AMPure XP beads kit (Beckman Coulter, Pasadena, CA, USA)
and submitted to a second PCR round for indexing, using the
Nextera XT index primers 1 and 2. After purification, PCR
productswerequantifiedusing theQuant-ITPicoGreen (Thermo
Fisher Scientific,Waltham,MA,USA) anddiluted to 10 ng/ml. A
final quantification, by quantitative PCR, of each sample in the
library was performed using the KAPA SYBR FAST qPCR Kit
(KapaBiosystems,Wilmington,MA,USA)beforenormalization,
pooling, and sequencing on aMiSeq sequencer using v3 reagents
(Illumina, San Diego, CA, USA).
The 16S rRNA gene reads were processed with the mothuR
package (23). The quality of all sequence reads was denoised us-
ing the Pyronoise algorithm implemented inmothuR and filtered
with the following criteria: minimal length of 425 bp, an exact
match to the barcode, and 1 mismatch allowed to the proximal
primer. The sequences were checked for the presence of chime-
ric amplifications using Uchime. The resultant read sets were
compared with a reference dataset of aligned sequences of the
corresponding regionderived from the SILVAdatabase (v1.19) of
full-length rRNA gene sequences implemented in mothuR (24).
The final reads were clustered into operational taxonomic units
(OTUs) using the nearest neighbor algorithmusingmothuRwith
a 0.03 distance unit cutoff. A taxonomic identitywas attributed to
each OTU by comparison with the SILVA database (80% homo-
geneity cutoff). As mothuR is not dedicated to the taxonomic
assignment beyond the genus level, all unique sequences for each
OTUwere comparedwith the SILVAdataset 111 using BLASTN
algorithm. For each OTU, a consensus-detailed taxonomic iden-
tification has been given based on the identity (,1% ofmismatch
with the aligned sequence) and the metadata associated with the
best hit (validated bacterial species or not).
SCFA measurement in feces
SCFA assay was performed by gas chromatography in super-
natant of ortho-phosphoric acid-treated feces as previously de-
scribed (25).
Tissue sample collection
AtPND21and274, 17 (n=9CTRLandn=8scFOS)and24 (n=11
CTRL and n = 13 scFOS) pigs, respectively, were euthanized in
our experimental slaughterhouse by electrical stunning and
exsanguination (Fig. 1). After opening the intestinal cavity, por-
tal blood was collected (PND 21) in tubes containing the
dipeptidylpeptidase-IV inhibitor (10 ml/ml blood; EMD
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Figure 1. Overview of the study design. Twenty-nine sows and their piglets were used in 2 replicates (n = 17 in R1 and n = 12 in
R2). From 28 d before the presumed day of farrowing, sows were fed either a control diet (n = 15, CTRL group) or scFOS-
supplemented diet (n = 14, scFOS group) until the end of the lactation. Plasma was collected in suckled piglets (n = 170) at PND
21 and in weaned pigs at PND 77 (n = 79), PND 190 (n = 35), and PND 253 (n = 35) to analyze glucose homeostasis at different
stages. An IVGTT was performed at the end of the experiment at PND 267 (n = 24) to evaluate the glucose homeostasis. Fecal
contents were collected at PND 21, PND 190, PND 211, and PND 253 (n = 14/age of collect) to determine the SCFA production,
reﬂective of the fermentative activity of the microbiota. Seventeen piglets were euthanized at PND 21 to investigate the
development of the enteropancreatic axis, and 24 pigs were euthanized at the adult stage to evaluate the adaptation of the
enteropancreatic axis to 3 mo of the HF diet.
scFOS PROGRAM GUT MICROBIOTA AND METABOLIC HEALTH 3
Downloaded from www.fasebj.org by BHAM/Liege/Fac/Medicine (139.165.31.15) on October 10, 2018. The FASEB Journal Vol. ${article.issue.getVolume()}, No. ${article.issue.getIssueNumber()}, primary_article.
nodes (MLNs) were removed and placed immediately in HBSS
(MilliporeSigma, Saint-Quentin Fallavier, France), supple-
mentedwith 2% fetal calf serum (FCS), 100 IU/ml penicillin, and
100 mg/ml streptomycin (MilliporeSigma) for mononuclear im-
mune cell isolation. Ileal biopsies (with and without the Peyer’s
patch)wererinsedwithPBScontaining1%DTT(MilliporeSigma)
and 1% FCS and then placed in medium made with 74% PBS,
25% DMEM (MilliporeSigma), and 1% FCS, supplemented
with 5 g/ml gentamicin (MilliporeSigma) and 1.2 mg/ml
amphotericin B (MilliporeSigma) for immediate explant cul-
ture. Intestinal tissues from distal ileum (10 cm proximal to the
ileocecal junction), cecum (distal part, i.e., bottom of the organ),
and proximal colon (at the end of the first third of colon; PDN 21
and274)were collected, rinsedwith coldPBS, and stored at280°C
until GLP-1 extraction and assay. For later immunohisto-
chemical analyses, samples of 1 cm3were dissected fromcecum
and from the pancreas body and fixed in 4% paraformalde-
hyde. Another sample of the pancreas body was collected and
stored immediately at280°C for insulin extraction. In addition,
at PND 274, a 5 cm ileal segment was rinsedwith cold PBS, and
collected ileal lavage was stored at 220°C until secretory IgA
(sIgA) analysis.Mucosawas scrapped froma 10 cm ileal segment
for further intestinal alkaline phosphatase (IAP) assay. Samples of
dorsal longissimus muscle and visceral and dorsal subcutaneous
adipose tissuewere frozen in liquid nitrogen and stored at280°C
until further molecular biology analysis.
Intravenous glucose tolerance test
At PND 253, under general anesthesia, a catheter was inserted
into 1 external jugular vein of the animals (26) (n = 11 CTRL and
n = 13 scFOS). One week after surgery and overnight food
withdrawal, the intravenous glucose tolerance test (IVGTT) was
performed, consisting in multiple blood samplings: 2 basal
samples were taken at 30 and 15 min before the intravenous
glucose injection (0.5 g/kg body weight) and at 0 (just after the
end of glucose injection), 3, 6, 10, 15, 20, 25, 30, 35, 40, 50, 60, and
75 min after glucose injection. Blood was collected in tubes con-
taining EDTA (or EDTAplus a dipeptidylpeptidase-IV inhibitor,
as described previously in Tissue sample collection). After cen-
trifugation at 2500 g for 10 min at 4°C, plasma samples were
stored at 220°C (or 280°C for GLP-1 assay-dedicated samples)
for later analyses. Insulin and glucose assays were performed on
all plasma samples. GLP-1 assays were only performed on basal
samples. The incremental area under the curve (AUC) was cal-
culated over 75 and 30 min for glucose and insulin. The acute
insulin response (=mean insulin concentration above basal val-
ues for the first 6min) and the rate of glucose disappearance (KG;
=the negative slope of the regression line obtained with the log-
transformedplasmaglucose values from3 to 30min, inpercentage
perminute) were also calculated. Insulin sensitivitywas evaluated
from fasting basal values of glucose and insulin using the homeo-
stasis model assessment insulin-resistance index [HOMA-IR; =
(basal value of glucose3 basal value of insulin)/22.5] and by cal-
culating the insulin-sensitivity index 2 (S2), described to be well
correlated to the insulin-sensitivity index obtained by the gold
standard euglycemic hyperinsulinemic clamp (27) and taking into
account AUC0–30 min of insulin and KG. The glucose and insulin
responseswerealso integratedusing theminimalmodel,described
byBergman (28), toobtain the insulin-sensitivity indexSI, aswell as
the glucose efficiency index (SG).
Hormone, glucose, lipid, and inflammatory
marker assays
Insulin content was extracted from the pancreas in 20 ml etha-
nol acid solution (1.5% HCl 12 M, 75% absolute ethanol, 23.5%
H2O;Polytron3100;Kinematica, Bohemia,NY,USA;24,000 rpm,
23 20 s). Insulin concentrations were measured on plasma and
pancreas extracts (dilution 1:3000) by a commercially available
radioimmunoassay kit using iodinated porcine insulin (Insulin-
CT; Cisbio Bioassays, Codolet, France). GLP-1 content was
extracted from ileal mucosa, cecum, and colon by homogeniza-
tion of 1 g tissue in 5ml ethanol acid solution (1%HCl 12M, 74%
absolute ethanol, 25% H2O; Polytron 3100; Kinematica; 24,000
rpm, 2 3 20 s). Then, a GLP-1 concentration was measured in
plasma and intestinal samples (dilutions 1:1000, 1:200, and 1:250
for ileal mucosa, cecum, and colon, respectively) using a com-
mercially available GLP-1 (active) ELISA kit (EMDMillipore).
Plasma glucose, nonesterified fatty acids, triglycerides, cho-
lesterol, and haptoglobin were assessed by an automated spec-
trophotometric method (Konelab 20i; Thermo Fisher Scientific,
Illkirsh, France) using specific commercial kits for each marker
(BioMe´rieux, Bruz, France). Plasma LPSwasmeasured using the
porcine LPS ELISA kit (MyBioSource, SanDiego, CA,USA). The
concentration of bioactive phosphatase alkaline was deter-
mined in ilealmucosawith a commercial kit (Sensolyte;Anaspec,
San Jose, CA, USA) using paranitrophenyl phosphate as the
substrate. Alkaline phosphatase activity concentrations were
expressed per milligram of soluble protein.
sIgAwasmeasured in ilealwashes.Once collected, samplesof
ilealwasheswerehomogenizedandcentrifuged for10minat4°C
at 500 g, and supernatants were collected and stored at 220°C
until analysis of the total sIgA level using the swine IgA ELISA
Quantitation Kit (Bethyl Laboratories, Montgomery, AL, USA).
Finally, MLN cells were isolated by mechanical dissociation
before purification over a density gradient (Histopaque, density
of 1.077 g/ml; MilliporeSigma) and cultured for 72 h at 37°C
under an atmosphere containing 5% CO2, as we previously de-
scribed (21). Culture of both types of ileal biopsies (with and
without the Peyer’s patch) were processed, as already described
(29), and incubated for 20 h. Three different conditions of culture
were performed for MLN cells and biopsies: unstimulated con-
dition, in the presence of 5 mg/ml concanavalin A [ConA; from
Canavalia ensiformis (Jack bean); MilliporeSigma], or in the pres-
ence of 10 mg/ml LPS (ultrapure LPS, from Escherichia coli 0111:
B4strain; InvivoGen,Toulouse,France) forMLNcells and25mg/
ml LPS (from E. coli 055:B5 strain; MilliporeSigma) for biopsies.
Supernatantswere collected and stored at220°C for later cytokine
analysis by ELISA (R&D Systems Europe, Lille, France). Concen-
trationswere expressed in picograms permilliliter of supernatants
forMLN cells (IFN-g, TNF-a, IL-10) and picograms per milligram
of tissue for explant cultures (IFN-g, TNF-a, IL-10, IL-8).
Immunohistochemical analyses
After fixation for 24 h in 4% paraformaldehyde, pancreas and
cecum samples were cryoprotected overnight at 4°C in PBS
containing 30% sucrose, embedded in the optimum cutting
temperature compound (TissueTek; Sakura Finetek Europe,
Zoeterwoude, The Netherlands), frozen in isopentane, and sec-
tioned (10 mm) using a cryostat-microtome. Immunohistochem-
ical analysis of pancreas was processed, as previously described
(30), to obtain the number, area of islets, and percentage of en-
docrine tissue. Cecum sections were incubated with PBS con-
taining4%normal horse serumand0.5%TritonX-100 for 30min.
Sections were then exposed overnight to a rabbit anti-GLP-1
antibody (1:500; Abcam, Cambridge, United Kingdom). After
washing with PBS, they were incubated with an anti-rabbit an-
tibody conjugated with FITC (1:200; Jackson ImmunoResearch
Laboratories, West Grove, PA, USA) for 3 h. Sections were
washed again with PBS, coverslipped with Vectashield (Vector
Laboratories, Burlingame, CA, USA), and examined with a
fluorescence microscope (Eclipse E400; Nikon Instruments
France, Champigny-Sur-Marne, France) attached to a digital
camera (Digital Still DXM 1200; Nikon Instruments France). The
whole section of the tissue was scanned using a digital slide
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scanner (Nanozoomer 2.0-RS; Hamamatsu Photonics France,
Massy, France). Recorded fileswere analyzed using the software
NDPI (Hamamatsu Photonics France) for determination of the
number of GLP-1-secreting cells per area of mucosa.
RNA extraction and real-time quantitative PCR
To characterize sensitivity of peripheral tissues to insulin, we
analyzed mRNA levels of GLUT-4 and insulin receptor
(INSR) in long back muscle, subcutaneous and visceral adi-
pose tissues, plus sterol regulatory element-binding tran-
scription factor 1C (SREBP1C) in both adipose tissues—the
level of these mRNA being well correlated to protein ex-
pression in these tissues (31, 32). Total RNA from adipose
tissue and muscle samples was extracted via the Trizol
method (Thermo Fisher Scientific, Waltham, MA, USA).
Extracted RNA samples were quantified using a NanoDrop
ND-1000 spectrophotometer (Thermo Fisher Scientific, Wal-
tham, MA, USA). The RNA quality was verified using the
Agilent RNA 6000 Nano kit and an Agilent 2100 Bioanalyzer
(Agilent Technologies France, Massy, France). All samples
met quality criteria. All extracted RNA exhibited an RNA
Integrity Number.7. Total RNA (2 mg) was used for reverse
transcription, performed according to the manufacturer
protocol (High Capacity Complementary DNA Reverse
Transcription Kit; Thermo Fisher Scientific, Waltham, MA,
USA). Real-time PCR was performed with the StepOnePlus
real-time PCR machine using SyberGreen master mix
(Thermo Fisher Scientific, Waltham, MA, USA) for detection.
For each primer pair, efficiencies of PCR were measured by
the slope of a standard curve using serial dilutions of a pool of
cDNA from the present experiment. In this experiment, they
ranged from 95 to 100%, with R2. 0.99. The relative quantity
of target gene transcripts was normalized against the geo-
metricmean of 3 or 2 housekeeping genes and analyzed using
the DDCt method (33). In this experiment, Ribosomal Protein
L4 (RPL4), Glyceraldehyde-3-Phosphate Dehydrogenase
(GAPDH), and Tyrosine 3-Monooxygenase/Tryptophan 5-
Monooxygenase Activation Protein Zeta (YWHAZ) were
used as housekeeping genes for muscle and visceral adipose
tissue samples, whereas GAPDH and Hypoxanthine phos-
phoribosyltransferase 1 (HPRT1) were identified as stable
reference genes for subcutaneous adipose tissue samples, as
they exhibit high-stability values among samples and were
not significantly affected by dietary treatments (Supple-
mental Table 2). Relative quantification of genes of interest
was obtained comparing the treated group (scFOS) with the
untreated group (CTRL).
Statistical analysis
With the consideration of microbiota analysis, statistical differ-
ences of population abundance between groups were assessed
with ANOVA, corrected for multitesting (Benjamini-Hochberg
False Discovery Rate) using STAMP software (http://kiwi.cs.dal.
ca/Software/STAMP) (34). Statistical differences of specific
bacterial populations between the same age groups were
assessed by 2-way ANOVA and Tukey-Kramer post hoc test
usingGraphPadPrismsoftware (v.6.04 forWindows;GraphPad
Software, La Jolla, CA, USA;www.graphpad.com). All other data,
not relating to the composition of themicrobiota,were subjected
to ANOVA using R Core Team (2013; R Foundation for Statis-
tical Computing, Vienna, Austria; http://www.R-project.org/).
Two-wayANOVA,with diet (CTRL vs. scFOS), replicate (R1 vs.
R2), and their interaction as factors, was performed for body
weight, body composition, and metabolic and inflammatory
parameters at each age. Adult pig body weight and energy in-
take during the HF diet period were subjected to ANOVAwith
repeated measurements, including diet (CTRL vs. scFOS), time
(weeks), replicate (R1 vs. R2), and the interactions between diet
and time anddiet and replication.Whendiet effect or interaction
between diet and time was significant, differences between di-
etary groups at each time were further measured by Tukey post
hoc test. Insulin and glucose responses to IVGTT were analyzed
byANOVAwith repeatedmeasurements, including diet (CTRL
vs. scFOS), time (minutes after glucose injection), replication (R1
vs. R2), and the interactions between diet and time and diet and
replication, followed by Tukey post hoc test. Correlations among
all parameterswereevaluatedusingSpearman’sRho (R) test.All
data are presented as means 6 SEM. Statistical significance was
defined as P# 0.05, and trend was reported as P# 0.10.
RESULTS
Early scFOSsupplementationdidnotmodifybodyweight
at any stage of development (until PND 190;Table 1). The
HF diet did not induce any further growth differences
between scFOS and CTRL pigs (Fig. 2A). The energy in-
take of the HF diet decreased continuously with time, ex-
cept during the first week, with a peak of energy intake
(Fig. 2B) being higher for the scFOS group than for CTRL
pigs (P = 0.02) but without differences on growth between
both groups (Fig. 2A). Moreover, scFOS pigs tended to
ingestmore energyduring the eighthweek (P=0.07) of the
HF diet (Fig. 2B).
TABLE 1. Growth performance from birth to PND 274 and body composition (PND 253–274) of pigs
born from sows supplemented with scFOS or not during the perinatal life
Parameter CTRL scFOS Diet P value
Body weight
Birth, kg 1.46 6 0.03 1.40 6 0.02 0.11
PND 28, kg 9.15 6 0.14 9.02 6 0.16 0.54
PND 56, kg 19.48 6 0.41 19.74 6 0.49 0.66
PND 190, kg 146.7 6 3.4 147.3 6 3.6 0.56
HF transition
Body weight PND 274, kg 214.7 6 3.3 217.6 6 4.4 0.80
Subcutaneous fat thickness PND 253, mm 24.4 6 1.3 24.6 6 1.7 0.86
Visceral adipose tissue PND 274, g/kg 15.83 6 0.92 20.31 6 1.47 0.02
Relative cecum weight PND 274, g/kg 0.98 6 0.06 0.99 6 0.07 0.65
Relative colon weight PND 274, g/kg 10.66 6 0.52 11.11 6 0.72 0.41
Mean values 6 SEM. CTRL, perinatal control diet; HF, high-fat diet; PND, postnatal day; scFOS,
perinatal short-chain fructooligosaccharide supplemented diet.
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Early scFOS intake modified fecal microbiota
composition and fecal SCFA content and
impacted the glucose metabolism of
suckling piglets
In 21-day-old piglets nursed by sows supplementedwith
scFOS, the abundance of bacteria belonging to Bacter-
oidetesphylumwas increased (P, 0.001),whereas that of
bacteria fromFirmicutes phylumwas reduced (P, 0.001;
Fig. 3A). At the genus level, maternal scFOS supplemen-
tation induced a higher relative proportion of Prevotella
(P,0.001),Bacteroidales_unclassifed (P,0.01),andTreponema
(P , 0.001) and a reduction of Bacteroides (P , 0.001) and
Ruminococcaceae_unclassified (P, 0.001; Fig. 3A). The highest
proportion of Treponema was specifically linked to 1 piglet.
The fecalSCFAcontentwasalsomodifiedwithan increase in
total SCFA concentration in feces of suckling piglets whose
mothers received scFOS supplementation (P = 0.001;
Table2),moreparticularly, acetate,propionate,valerate, and
caproate (P , 0.05). Yet, these differences in fecal SCFA
concentrationswerenotmaintainedafterweaningat the end
of the scFOS supplementation (PND 50; Table 2).
Plasma insulin concentration of scFOS piglets at PND
21 was reduced (P = 0.02) with no difference in glycemia,
resulting in a lower insulin/glucose ratio (P = 0.02;
Table 3). In addition, plasmaGLP-1 concentration tended
to decrease at PND 21 in scFOS piglets (P = 0.09) without
modulation of the density of GLP-1-secreting L-cells in the
cecal part of the intestine (Table 3). The proportion of
pancreatic endocrine tissue was significantly decreased in
scFOSpiglets (P=0.01), aswell as thepancreatic content of
insulin (P = 0.05; Table 3). In addition, the macronutrient
composition of sow’s milk, measured 3 wk after farrow-
ing, indicated that scFOS-supplemented sows produced
milkwithhigherdrymatter (P=0.004), lipid (P=0.01), and
protein (P = 0.09) contents, resulting in a higher energy
value (P = 0.005; Supplemental Table 3).
The early changes in fecal microbiota were
maintained in older pigs independently of
the diet
AtPND190,while theywere feda standarddiet,pigs from
the scFOS group displayed a higher proportion of Bac-
teroidetes phylum (P , 0.001), as a consequence of the
increase of the Prevotella genus abundance (P, 0.001; Fig.
3B). A higher proportion of the Lachnospiraceae_unclassified
genus (P, 0.001)wasalsoobserved in the scFOSgroup. In
addition, the early scFOS supplementation induced a de-
crease in the proportion of Ruminococcaceae_unclassified
and Bacteroidales_unclassified genuses (P , 0.05; Fig. 3B).
However, the fecal SCFA concentrations were not differ-
ent between groups (P = 0.76; Table 2).
Three weeks after the beginning of the HF diet (at PND
211), scFOS pigs tended to display a higher acetate con-
centration in feces (P= 0.09), but it did not persist 6wk later
(at PND 253; Table 2). However, the microbiota composi-
tion differed betweenCTRLand scFOSgroups at PND253.
Adult scFOSpigs, under anHFdiet, displayedan increased
proportion of Proteobacteria phylum (P , 0.01) without
any changes in the 2 main phyla (Firmicutes and Bacter-
oidetes; Fig. 3C). At the genus level, the proportion of Pre-
votella was still higher in the scFOS group (P , 0.001; Fig.
3C). Interestingly, the Prevotella genus abundance was
positively correlated to total SCFA concentration in fecal
content (P, 0.05; R = 0.48).
Early scFOS supplementation programmed
the enteroinsular axis and glucose
metabolism in adult pigs
At PND 253, the GLP-1-secreting L-cell density in the ce-
cum was higher (+33%) in the scFOS group compared
withCTRL pigs (P = 0.03; Fig. 4A). Concomitantly, fasting
plasma GLP-1 concentration tended to increase approxi-
mately twice in the scFOSgroup comparedwith theCTRL
group (P = 0.09; Fig. 4B). Interestingly, these 2 parameters
were positively correlated (P = 0.05, R = 0.47). In the pan-
creas, no difference was measured on the proportion of
endocrine tissue (0.976 0.16% for CTRL and 0.966 0.09%
for the scFOS group) nor on the insulin content (6.70 6
1.61mUI/g for CTRL and 7.206 1.57mUI/g for the scFOS
group). However, the pancreatic insulin content was
Figure 2. Body weight and food intake in adult pigs. A) Growth
of adult pigs (n = 17 CTRL and n = 18 scFOS). Growth increased
signiﬁcantly with time (P , 0.001), whatever the perinatal diet.
B) Energy intake expressed in mega joules per day per kilogram
of body weight (BW; n = 17 CTRL and n = 18 scFOS). Energy
intake decreased with time (P , 0.001), and a tendency to an
interaction between perinatal diet and time (P = 0.09) was
observed. CTRL, perinatal control diet; HF, high-fat; scFOS,
perinatal short-chain fructooligosaccharide supplemented diet.;
W, weeks after the beginning of the HF diet. Mean values6 SEM.
*P , 0.05 vs. CTRL, #P , 0.10 vs. CTRL.
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positively correlated to the density of cecal GLP-1 L-cells
(P = 0.001, R = 0.65).
Plasma fasting glucose and insulin concentrationswere
not different between groups, neither before (PND 190)
nor after the HF diet period (PND 253; Table 4), nor were
the lipid concentrations (triglycerides, free fatty acids, and
total cholesterol; data not shown). When the glucose ho-
meostasis was challenged by an intravenous injection of
glucose (IVGTT), scFOS animals secreted more insulin
than CTRL animals with no difference in glucose profile
(Fig. 5). Calculated indexes from insulin and glucose
profiles resulted in a tendency to a higher insulin AUC
between 0 and 30min after glucose injection in scFOS pigs
(P = 0.07), as well as a reduction in S2 (P = 0.09) and in SI
(P = 0.02) indices (Table 4). A negative correlation was
established between glucose AUC0–30 min and the cecal
GLP-1-producing L-cells (P = 0.001, R =20.62).
Interestingly, the HOMA-IR index was negatively
correlated to the relative abundance of Prevotella (R =
20.64), but positively to the Ruminococcaceae_unclassified
genus (R = 0.66). Conversely, plasma GLP-1 concentra-
tion was negatively correlated to the proportion of the
Ruminococcaceae_unclassifiedgenus (R=20.60) but positively
to total SCFA (R = 0.66), acetate (R = 0.67), propionate
(R = 0.53), and butyrate (R = 0.54) in feces.
Early scFOS intake did not modify insulin
sensitivity but reduced proinflammatory
cytokine expression in visceral adipose tissue
Nodifference in subcutaneous adiposity but an increase in
visceral adipose tissue weight was noticed in scFOS pigs
(P=0.02).Nootherdifference in relative organweightwas
recorded between groups at slaughter (Table 1). None of
the studied genes representative of insulin sensitivity in
muscle and adipose tissues displayed differences in
mRNA levels between CTRL and scFOS groups at PND
273 (Table 5). TNF-a and IL-10 expression was not
different between scFOS and CTRL animals in the sub-
cutaneous adipose tissue, but TNF-a expression signifi-
cantly decreased in the visceral adipose tissue of scFOS
pigs comparedwith CTRL pigs (P = 0.02; Table 5). Plasma
Figure 3. Fecal microbiota composition analysis by 16S proﬁling. Mean phylotype distribution (phylum and genus levels)
expressed as cumulated relative abundance mean (n = 6 per group) at PND 21 during suckling (A), PND 190 after standard diet
feeding (B), and at PND 253 after a 3 mo period of HF diet feeding (C). CTRL, perinatal control diet; scFOS, perinatal short-
chain fructooligosaccharide supplemented diet; HF, high-fat. *↑↓P , 0.05 between groups at the same age.
TABLE 2. SCFA concentration in feces (millimoles per kilogram) of
pigs supplemented perinatally with scFOS or not
SCFA CTRL scFOS Diet P value
PND 21
Total SCFA 16.5 6 4.6 33.4 6 2.8 0.001
Acetate 10.0 6 2.7 20.5 6 1.5 0.003
Propionate 1.9 6 0.6 4.9 6 0.6 0.005
Butyrate 1.7 6 0.6 3.1 6 1.0 0.37
Valerate 0.37 6 0.12 1.03 6 0.28 0.04
Caproate 0.008 6 0.007 0.187 6 0.091 0.004
PND 50
Total SCFA 138.7 6 24.2 127.3 6 19.1 0.70
PND 190
Total SCFA 101.3 6 12.4 106.0 6 8.3 0.76
HF transition
PND 211
Total SCFA 90.1 6 6.1 114.1 6 13.2 0.12
Acetate 52.3 6 3.3 67.2 6 7.5 0.09
Propionate 18.9 6 1.3 23.0 6 2.4 0.16
Butyrate 10.7 6 1.3 13.7 6 2.4 0.28
PND 253
Total SCFA 91.4 6 16.1 87.5 6 7.1 0.83
Mean values 6 SEM. CTRL, perinatal control diet; PND, postnatal
day; scFOS, perinatal short-chain fructooligosaccharide supplemented
diet; HF, high-fat diet.
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haptoglobin andLPS concentrationswere notmodified by
early scFOS supplementation (Table 6).
Early scFOS intake improved intestinal
protection in adult pigs
Adult scFOS pigs displayed a tendency for an increased
IAP level in the ileal mucosa (P = 0.098) and a significant
increase in sIgA concentration in ileal washes (P = 0.03)
compared with CTRL pigs (Table 6). The concentration of
sIgA in ileal washes was positively correlated to the IAP
level (P = 0.03, R = 0.46) and negatively to the plasmatic
LPS (P = 0.02,R =20.48). In vitro stimulation ofMLN cells
from scFOS animals with ConA mitogen secreted more
IFN-g than those fromCTRL animals (P= 0.003), but there
was no difference when MLN cells were stimulated with
LPS (Table 6). The secretion of the other measured cyto-
kines (TNF-a and IL-10)wasnot different between groups
(Table 6) in both conditions (except LPS-induced IL-10
secretion, which tended to be lower in scFOS; P = 0.06).
Cytokine secretions (TNF-a, IL-10, IFN-g, and IL-8), after
in vitro culture of ileal explants, with and without the
Peyer’s patch, were not modified by early scFOS supple-
mentation (Supplemental Table 4).
DISCUSSION
Accumulating evidences suggest that nutrition during
fetal and early postnatal life programs microbial, meta-
bolic, and immune development in offspring, with later
consequences on their susceptibility tometabolic diseases.
We showed that scFOS supplementation, known to well
balance the gutmicrobiota during perinatal life, programs
the intestinal endocrine function with increased pan-
creas sensitivity to glucose in a GLP-1-dependent manner
through microbiota changes, as well as the resistance to
inflammation. This scFOS-induced programming may be
beneficial to cope with an unbalanced diet in adulthood.
We first analyzed the microbiota and metabolic profile
of suckling piglets whose mothers were supplemented
with scFOS or not. Our results demonstrated that it is
possible to modulate the microbiota establishment in
suckling piglets by maternal scFOS supplementation
during the perinatal period. Indeed, the bacterial compo-
sition of scFOS offspring displayed a higher proportion
of Bacteroidetes phylum and more particularly, an in-
crease in the Prevotella genus compared with the non-
supplemented CTRL group. Total SCFA content, notably
acetate, was increased in feces of suckling scFOS piglets.
TABLE 3. Glucose homeostasis and enteroinsular axis in suckling piglets (PND 21) born from sows
supplemented in scFOS or not during the perinatal life
Parameter CTRL scFOS Diet P value
Plasma
Glucose, mM 7.55 6 0.12 (n = 90) 7.29 6 0.16 (n = 79) 0.50
Insulin, mIU/ml 9.54 6 0.58 (n = 91) 8.24 6 0.61 (n = 79) 0.02
Insulin/glucose 1.26 6 0.08 (n = 90) 1.08 6 0.08 (n = 78) 0.02








2.87 6 0.20 (n = 6) 1.99 6 0.15 (n = 5) 0.01
Insulin content, IU/g 13.62 6 0.60 (n = 8) 11.43 6 0.84 (n = 6) 0.05
Mean values 6 SEM. Parameters were measured 1 h after breastfeeding. PND, postnatal day; CTRL,
perinatal control diet; scFOS, perinatal short-chain fructooligosaccharide supplemented diet.
Figure 4. GLP-1-secreting L-cell density in cecum and plasma
GLP-1 concentration at PND 273. A) GLP-1-secreting L-cell
density in cecum (n = 11 CTRL and n = 13 scFOS). B) Plasma
GLP-1 concentration after an overnight food withdrawal (n =
11 CTRL and n = 13 scFOS). CTRL, perinatal control diet;
scFOS, perinatal short-chain fructooligosaccharide supple-
mented diet. Mean values 6 SEM. *P , 0.05, #P , 0.10.
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This is consistent with the increase of Prevotella, known to
ferment complex carbohydrates and to produce high
amounts of SCFA (35). In connection with these early
microbiota modifications, the maternal scFOS supple-
mentation induced an improvement of the glucose toler-
ance in suckling piglets, as the amount of insulin required
to return to the basal glycemia after suckling was dimin-
ished. Maternal scFOS supplementation did not modify
the intestinal endocrine function, with the same L-cell
density and GLP-1 tissue content between both groups,
but reduced the development of the endocrine pancreas,
objectified by a reduction in endocrine tissue percentage
and insulin secretion by the pancreas, in associationwith a
tendency to a decreased plasmaGLP-1 concentration. The
difference of maternal milk composition, with an increase
in lipid content and energy value and a tendency formore
proteins with scFOS supplementation, could explain such
effects. In fact,amodulationof thedietduring theperinatal
life (via the maternal diet or directly by the postnatal diet)
can induce significant effects on endocrine pancreas de-
velopment and glucose tolerance (36–38). In addition, the
lower development of endocrine pancreas, a potential
consequence of a lower request of its endocrine function,
could be a result of an improved insulin sensitivity of the
peripheral tissues, as observed in rats fed by mothers
supplemented with 21.6% of oligofructose (OF)/inulin,
with an overexpression of uncoupling protein 1 and peroxi-
some proliferator-activated receptor-g coactivator 1a in adi-
pose tissue (39).
Afterward, we analyzed the programming effects of
such early modifications in adulthood. There was no
difference in fecal SCFA concentration between scFOS
and CTRL groups after weaning or in adulthood, con-
trary to our previous results showing an increase bu-
tyrate content in the distal intestine in 2 (20)- and
3-mo-old pigs (21). However, early scFOS-induced
differences in microbiota composition persisted until
adulthood, particularly the higher relative proportion
of the Prevotella genus. Accordingly, in another study in
rats, microbiota modulation in early life by maternal
OF/inulin intake (21.6% from conception to weaning)
induced persistent modifications with an increase of
Bifidobacterium spp. andClostridium coccoides in adult rat
offspring (40).
In associationwith thesemicrobiota changes,metabolic
parameters of the host were modulated by early scFOS
intake. Actually, a higher fasting GLP-1 concentration in
adult pigs that received early scFOS supplementation
correlated to a significant increased GLP-1-secreting L-cell
density in the cecum, indicating an increased capacity of
the scFOS adult offspring to secrete GLP-1. Adult rats,
following aperinatalOF supplementation, did not display
changes in postprandial GLP-1 level but showed an in-
crease in gastric inhibitory peptide concentration, another
incretin hormone, secreted by more proximal K cells (41).
Moreover, when ingested directly by healthy adults or
adults displaying deleterious metabolic conditions (as a
result of an HF diet or obesity), prebiotics increased the
number of intestinal GLP-1-producing L-cells, GLP-1
content, and circulating levels of GLP-1 in humans, rats,
and mice (42–49), which might, in turn, improve their
metabolic status (50). SCFAs, produced by the microbiota
after scFOS intake, increase the production and release of
GLP-1 by enteroendocrine L-cells in the intestine and favor
L-cell differentiation in crypts (47). In our study, perinatal
scFOS consumption displayed similar effects on L-cells,
7 mo after the end of supplementation. One explanation
could be the maintenance over time of a favorable micro-
biota, notably with high fermentative activity, established
during early life. This is supported by the positive
correlation observedbetween the SCFAproduction and
plasmatic GLP-1 concentration. Therefore, our data
demonstrated a programming of the intestinal endocrine
function, probably mediated by the early establishment
TABLE 4. Glycemia, insulinemia, and IVGTT indices before (PND 190) and after (PND 253) the 3 mo
of an HF diet in adult pigs supplemented perinatally with scFOS or not
Parameter CTRL scFOS Diet P value
PND 190 (standard diet)
Fasting glucose, mM 4.49 6 0.12 4.46 6 0.15 0.629
Fasting insulin, mIU/ml 18.70 6 1.29 18.17 6 2.08 0.436
HOMA-IR 3.80 6 0.32 3.80 6 0.64 0.440
PND 253 (HF diet)
Glucose, mM 4.75 6 0.12 4.84 6 0.12 0.872
Insulin, mIU/ml 17.54 6 2.47 18.15 6 1.97 0.878
HOMA-IR 3.77 6 0.55 4.03 6 0.53 0.956
IVGTT indices
AUCGlucose 0–30 min 503.5 6 21.8 521.8 6 14.8 0.483
AUCInsulin 0–30 min 4235.1 6 339.5 5316.5 6 430.8 0.068
AIRInsulin 0–6 min 114.5 6 9.5 136.6 6 11.6 0.164
KG (%/min) 4.19 6 0.42 4.0 6 0.27 0.695
S2 [min
21 × (mIU × ml21)21] 3.72 6 0.61 2.66 6 0.23 0.085
SI [10
4 × min21 × (mIU × ml21)21] 6.89 6 0.81 5.31 6 0.84 0.019
SG (10
2 × min21) 2.51 6 0.24 2.04 6 0.21 0.109
Mean values6 SEM. AIR, acute insulin response; AUC, area under the curve; CTRL, perinatal control
diet; HOMA-IR, homeostasis model assessment of insulin resistance; KG, rate of glucose disappearance;
PND, postnatal day; scFOS, perinatal short-chain fructooligosaccharide supplemented diet; S2 and SI,
insulin sensitivity indexes; SG, glucose efﬁciency index.
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of a beneficial microbiota composition and fermentative
activity, which persisted into adulthood.
Once released from intestinal L-cells, GLP-1 stimulates
insulin secretionandhasa trophic effect on thepancreasby
regulating islet cell proliferation anddifferentiation (9).No
difference was observed in pancreatic anatomy and in-
sulin content between scFOS andCTRL adult pigs, but the
scFOS group tended to secretemore insulin in response to
an intravenous glucose stimulus with no modification of
the glucose profile. This increased insulin release high-
lighted a higher pancreas sensitivity to glucose in scFOS
pigs, as they displayed no insulin resistance in their pe-
ripheral tissues. This could be a result of their higher basal
GLP-1 concentration, as suggested byChan et al. (51), who
demonstrated that the increase in doses of GLP-1 stimu-
lated insulin release during IVGTT in mice. The positive
correlation between GLP-1-secreting L-cell density and
pancreatic insulin content underlies such a role of GLP-1
on pancreas insulin-secretion capacity in our study. This
was in accordance with data in HF-fed diabetic mice, in
which OF supplementation, during 4 wk, was efficient to
reduce starvation and postprandial glycemia in associa-
tionwith increased levelsofplasmaandpancreatic insulin.
These results were obtained in a GLP-1-dependent man-
ner throughan increasedplasmaGLP-1 concentration and
total GLP-1 content in the proximal colon (44). In our
study, we did not observe changes of the glucose profile
during the IVGTT, but the negative correlation seen be-
tween AUCGlucose and the GLP-1-producing L-cells sup-
ported the role of intestinal endocrine function in the
regulation of glucose homeostasis. Interestingly, the ob-
served negative correlation between Prevotella abundance
and the HOMA-IR index may suggest that the increased
Prevotella proportion could be a key factor to prevent de-
velopment of insulin resistance.
The programming of the intestinal immune function,
which is also dependent of the microbiota composition
and its fermentative activity, was investigated in adult
pigs. Perinatal scFOS supplementation induced a benefi-
cial long-lasting effect on intestinal sIgA secretion and IAP
concentration (higher values of both parameters in scFOS
pigs), with no significant difference in plasma LPS. The
expression of IAP has been shown to be controlled by
the gut microbiota (52), as well as the sIgA release in the
TABLE 5. Expression of genes related to insulin sensitivity and inﬂammation in muscle and adipose
tissues in adult pigs supplemented perinatally with scFOS or not
Gene CTRL scFOS Diet P value
Muscle
GLUT4 1.01 6 0.04 1.00 6 0.08 0.67
INSR 1.02 6 0.06 1.11 6 0.06 0.28
Subcutaneous adipose tissue
GLUT4 1.11 6 0.16 0.83 6 0.08 0.12
INSR 1.05 6 1.00 0.86 6 0.08 0.14
SREBP1C 1.03 6 0.09 0.83 6 0.08 0.10
IL-10 1.12 6 0.15 1.45 6 0.24 0.66
TNF-a 1.10 6 0.13 1.22 6 0.18 0.59
Visceral adipose tissue
GLUT4 1.06 6 0.23 0.76 6 0.09 0.23
INSR 1.02 6 0.17 0.85 6 0.06 0.27
SREBP1C 1.01 6 0.12 0.76 6 0.09 0.20
TNF-a 1.03 6 0.20 0.50 6 0.09 0.02
Values are expressed as the ratio of the relative expression of the scFOS group to the CTRL group.
CTRL, perinatal control diet; scFOS, perinatal short-chain fructooligosaccharide supplemented diet.
Figure 5. Glucose and insulin responses to an IVGTT at PND 267.A)
Insulin proﬁle (n = 11 CTRL and n = 13 scFOS). B) Glucose proﬁle
(n = 11 CTRL and n = 13 scFOS). CTRL, perinatal control diet;
scFOS, perinatal short-chain fructooligosaccharide supplemented
diet. Mean values 6 SEM. *P , 0.05 vs. CTRL, #P , 0.10 vs. CTRL.
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intestinal lumen (53), in accordance with the persistent
microbiota modulation induced by perinatal scFOS sup-
plementation in adulthood. The increased sIgA secretion
could be linked to themodification of bacteria populations
andmore particularly, to the higher relative abundance of
Prevotella, as suggested by Mach et al. (54), showing a
positive correlation between Prevotella and sIgA luminal
concentration in weaned pigs. Intestinal sIgA secretion is
essential to prevent inflammatory responses by down-
regulating the expression of inflammatory cytokines, such
as TNF-a and IL-6 (55). Another regulator of intestinal
inflammation is IAP, which controls several gut biologic
processes, such as LPS detoxification, reducing its toxicity
for epithelial cells, inflammation, and bacterial trans-
location to the lymphoid organs (56). An increased IAP
activity may help to decrease chronically plasma LPS
concentration and thereby, may reduce metabolic endo-
toxemia, which contributes to HF diet-induced metabolic
disorders (50). Although there was no significant differ-
ence in plasma LPS, numeric values were 37% lower in
scFOS pigs, and once again, TNF-a expression in their
visceral adipose tissue was significantly decreased com-
pared with CTRL pigs. Accordingly, Hallam et al. (40)
showed a reduction of plasma LPS in adult rats sup-
plemented with prebiotics in early life, linked to a
higher abundance of Bifidobacterium spp., suggested to be
mediatedbymilk oligosaccharides. In our study,maternal
scFOS supplementation induced macronutrient composi-
tion differences in sow milk, which could contribute to
modulate the composition and the metabolism of the
microbiota colonizing the neonatal gut and consequently,
their long-lasting effects (40). Finally, there was a posi-
tive correlation between sIgA and IAP activity and a
negative one between sIgA and plasma LPS concentra-
tion, underlying a possible link between these different
inflammatory parameters. Overall, our data suggested
that scFOS adult offspring may be more resistant to
inflammation.
The pattern of growth was not affected by perinatal
scFOS supplementation nor was the body weight gain
during the HF challenge, even if scFOS pigs tended to
ingest more energy. Both groups regulated their energy
intake after the first week ofHFdiet transition and did not
develop hyperphagia. scFOS pigs displayed an increased
visceral adiposity at PND 274, but as adiposity is pre-
dominantly located in subcutaneous adipose tissue in pigs
(;65%), whereas internal adiposity represents only 5% of
total body fat (57), this reflected only a very slight quan-
titativeeffectonglobaladiposity. It had indeednoeffecton
the systemic inflammatory status and on the insulin sen-
sitivity of peripheral tissues. Interestingly, even if heavier,
the visceral tissue of scFOS pigs expressed less TNF-a
compared with the CTRL group. Hallam and Reimer (41)
showed a reduction in the percentage of total body fat in
adult rats fed an HF high-sucrose diet whose mothers had
been supplementedwith prebiotics. This discrepancy could
be explained by a species variability but also by the higher
dose of prebiotic and the different period of supplementa-
tion used in their study (21.6% during the whole gestation)
compared with ours (0.33% during the last one-third of
gestation and 0.15% for lactation and post weaning), as
well as the different diet composition in adulthood (41).
In summary, our studydemonstrated that the intestinal
endocrine function of adult pigs and their susceptibility to
inflammation is submitted to a nutritional programming
that may participate to the metabolic imprint. This pro-
gramming is highly connected to the microbiota. These
results are of high interest to understand nutritional pro-
gramming in humans and thus, to develop nutritional
strategies topreventmetabolicdisorders. Indeed,pigsused
as a model for humans are considered to be more relevant
than rodents, especially because there is higher similarity
in anatomy, physiology, metabolism, and microbiota be-
tweenhumans andpigs (58).Amongnutritional strategies,
perinatal scFOS supplementation, known to well balance
the microbiota durably, seems to be an interesting way to
prevent metabolic disorders and susceptibility to inflam-
mation later in life, notably when confronted with a dele-
terious nutritional environment.
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